⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 5, 2026Liver International

Radio‐ HVPG : Considerations and Limitations for Risk Prediction in Patients With Cirrhosis

Martina Scharitzer Katharina Lampichler Clemens Watzenböck Thomas Reiberger

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to analyze considerations and limitations in risk prediction for patients with cirrhosis using HVPG measurements.
Discusses theoretical aspects of HVPG measurements in risk prediction for cirrhosis.
Reviews current literature on biomarkers associated with portal hypertension.
Explores limitations of current methodologies in assessing risk.
Highlights the importance of hemodynamic monitoring in predicting outcomes in cirrhotic patients.
Identifies gaps in data when using HVPG for risk assessment.
Suggests the need for improved methodologies to enhance prediction accuracy.

Implication

Risk prediction considerations and limitations are discussed for patients with cirrhosis, indicating implications for clinical practice.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Scharitzer et al. (2026) studied this question.

synapsesocial.com/papers/6a250baa7def13d035e1ba81 https://doi.org/10.1111/liv.70730

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Considerations on <scp>CT</scp> ‐Based Radiomics for <scp>HVPG</scp> Prediction in CirrhosisOriginal Research · 2026 · 1 citations
2Radiomics‐Based Assessment of Portal Hypertension Severity and Risk Stratification of Cirrhotic Patients Using Routine <scp>CT</scp> ScansRetrospective Study · 2026 · 3 citations
3Individualized <scp>HCC</scp> surveillance using risk stratification scores in advanced fibrosis and cirrhotic <scp>HCV</scp> patients who achieved <scp>SVR</scp>: Prospective study2024 · 13 citations
4Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After <scp>SVR</scp>Original Research · 2026 · 1 citations
5Response to Commentary on “Impact of Disease‐Specific Treatment and <scp>NSBBs</scp> on Risk of <scp>PVT</scp> in Cirrhotic Patients With <scp>HCV</scp> or <scp>PBC</scp> ”Original Research · 2026